Spots Global Cancer Trial Database for Prediction of Lymph Node Invasion for Prostate Adenocarcinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Prediction of Lymph Node Invasion for Prostate Adenocarcinoma

Official Title: Prediction of Lymph Node Invasion in Patients Operated on for Prostate Adenocarcinoma

Study ID: NCT04909957

Conditions

Adenocarcinoma of the Prostate

Interventions

Study Description

Brief Summary: Despite lymph node involvement (LNI) being one of the main prognostic factors in patients with prostate cancer (PCa), pelvic lymph node irradiation remains debated, possibly due to an insufficient selection of patients. Significant advances in LNI risk modelling have been achieved with the addition of visual interpretation of magnetic resonance imaging (MRI) data, but it is likely that quantitative analysis could further improve prediction models. In this study, the investigators aimed to develop and internally validate a novel LNI risk prediction model based on radiomic features extracted from pre-operative multimodal MRI.

Detailed Description: